Chiron

Chiron raises a $1.2M seed round, led by THENA Capital with participation from Arāya Ventures ������\n\nFounder Carron Manning and team are building the intelligence layer for personalised self-management, enabling healthcare providers to deliver continuous, adaptive care beyond the clinic. \n\nTheir platform combines electronic health records, wearable data and patient-reported outcomes to build and refine personalised self-management programmes for every individual, giving clinicians a continuous window into what happens between appointments.\n\nEarly deployments with a chronic pain population have demonstrated a 31% improvement in clinical outcomes. The platform holds UKCA Class I medical device status, has completed a fully funded NHS pilot and has received funding from Innovate UK and the Medical Research Council.\n\nChiron was originally spun out of the Founders Factory Venture Studio in partnership with Reckitt, and it has been exciting to watch the team build from that foundation into a fully validated, clinically evidenced platform.\n\nThis round will accelerate deployment across NHS Integrated Care Boards and Primary Care Networks, while laying the commercial and regulatory foundations for entry into the US market.\n\nCongratulations to Carron, COO Dr Karen Lawson, CTO Davide Crescenzi and the entire Chiron team. \n\nRead about the raise in Femtech Insider: https://t.co/z56T3TRTgz\n\n#Fundraising #Healthtech